Public CROs Craft New Strategies to Achieve Financial and Strategic Objectives

News
Article
Pharmaceutical TechnologyPharmaceutical Technology-03-02-2002
Volume 26
Issue 3

Public CROs are creating new ways of operating their outsourcing businesses to remain competitive in difficult economic conditions.

External Link - article-12403.pdf

Articles in this issue
Outsourcing Outlook
Developing Custom Adhesive Systems for Transdermal Drug Delivery
Overview of Technologies Supporting Security Requirements in 21 CFR Part 11, Part II
PDA Task Force Issues Guidelines to Aid Isolator Users
Recent Advances in Semisolid Dosage Forms for Dermatological Application
Drug Safety Concerns Shape Manufacturing Policy
Production Information Mangement
Functionality Testing of a Multifunctional Directly Compressible Adjuvant Containing Lactose, Polyvinylpyrrolidone, and Croscarmellose Sodium
Public CROs Craft New Strategies to Achieve Financial and Strategic Objectives
Validation Changes to the USP Assay Method for Ibuprofen Tablets
Systematic Troubleshooting for LC/MS/MS
Product Development Issues of Powders for Injection
Oral Low Molecular Weight Heparin Absorption From Solution and Solid Dosage Forms in Rat, Dog, and Monkey Models
Pharmaceutical Reserch and Manufacturers Association Acceptable Analytical Practice for Analytical Method Transfer
Recent Videos
AAPS National Biotechnology Conference 2025: High-Concentration Biologics
AAPS National Biotechnology Conference 2025: High-Concentration Biologics
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Tariff Pause Reinforces Uncertainty Among Biopharma Professionals
Industry Outlook 2025: Evolving Pipelines and Supply Chain
Industry Outlook 2025: Evolving Pipelines and Supply Chain
Drug Digest: Strategic Partnerships
Drug Digest: Strategic Partnerships
DCAT Week 2025: Industry Need for Continuous Biologics Manufacturing
DCAT Week 2025: Industry Need for Continuous Biologics Manufacturing
Henny Zijlstra from Adragos Pharma chats about the trends affecting the outsourcing market, various strategies being employed by service providers, and the value of end-to-end services.
DCAT Week 2025: Gaining End-to-End Clarity
DCAT Week 2025: Keeping Up with Drug Demand
DCAT Week 2025: Keeping Up with Drug Demand
DCAT Week 2025: Expanding Sterile Injectables Capacity
DCAT Week 2025: Expanding Sterile Injectables Capacity
DCAT Week 2025: A Discussion on Aseptic Processing for Sterile Injectable Manufacturing
DCAT Week 2025: A Discussion on Aseptic Processing for Sterile Injectable Manufacturing
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
DCAT Week 2025: Recognizing the Value of CDMOs
Related Content
Darmstadt, Germany - November 10, 2021: A building at the headquarters of science and technology company Merck KGaA. | Image Credit: © Anne Czichos - stock.adobe.com

Merck KGaA Becomes Strategic Partner in Peregrine Ventures’ Incentive Incubator

Patrick Lavery
May 15th 2025
Article

Merck will have early-stage opportunities to help startups set up for future success in the pharmaceutical and life sciences fields.

Drug Solutions Podcast: Unlocking the Latest Manufacturing Trends

Drug Solutions Podcast: Unlocking the Latest Manufacturing Trends

Felicity Thomas
July 11th 2023
Podcast

In this episode, Sergey Vlasenko from Agilent chats about bio/pharmaceutical manufacturing trends, with a particular focus on oligonucleotides.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Piramal Pharma to Invest $90 Million at Kentucky & Michigan Sites

Patrick Lavery
May 12th 2025
Article

The company said the investment is in response not only to customer demand and a belief in the value of US-based innovation, but also because of the trend toward US onshoring brought about by new tariff policies.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
May 2nd 2023
Podcast

In this episode, Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Unidentified microbiologist is place the petri dish and tubes into incubator to incubate the culture of bacteria or fungi growth in appropriate condition, concept of microbial laboratory. | Image Credit: © Sukjai Photo – © Sukjai Photo – Stock.Adobe.com

Evolving Cleanroom Procedures and Sterility Challenges

Feliza Mirasol
May 6th 2025
Article

The shift toward personalized medicines poses new challenges in cleanroom protocols.

Image Credit: © Kiattisak – stock.adobe.com

Authentic Intelligence: Finding Diverse Talent in the Age of AI

Patrick Lavery
May 4th 2025
Article

The pandemic made it daunting for companies to retain talent and then find it anew, but just as that cloud is lifting and workforce diversity is being embraced, AI beckons as a new challenge.